Artriphen Recalled By XYMOGEN Over Undeclared Allergen Risk

Posted on May 9, 2013

The Orlando, Florida-based XYMOGEN has announced the recall of artriphen because of concerns that the item will contain milk and soy without the label declaring as much.  The company reportedly issued this recall once they discovered that a supplier’s allergen checklist did not match up with the labels on the product.  The allergens’ presence was confirmed during lab testing.  If consumers that are sensitive to either of the aforementioned allergens consume the products, which are used to help aid the health of a person’s joints, they could potentially suffer a severe allergic reaction.  Persons who believe they would be at risk upon consumption of the products should refrain from using the items and instead get in touch with XYMOGEN to learn about recall instructions.

For more about the recall, click here.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.
*Required Fields